Methylene Blue Clinical Trials
3 recruitingDrug
Phase 22Phase 11
Showing 1–3 of 3 trials
Recruiting
Phase 1
Adjunctive Methylene Blue for Immunotherapy-related CRS and ICANS: Phase I Study
Cytokine Release SyndromeICANS
Institute of Hematology & Blood Diseases Hospital, China18 enrolled1 locationNCT07169487
Recruiting
Phase 2
Methylene Blue Treatment of Chronic Hepatitis B Virus Infection
Chronic HBV Infection
Fondazione Epatocentro Ticino10 enrolled1 locationNCT06887036
Recruiting
Phase 2
Methylene Blue for the Prevention of Hypotension During Hemodialysis
Acute Kidney InjuryShock
Federal University of São Paulo260 enrolled1 locationNCT05092165